What is the role of inotuzumab ozogamicin in ALL
The exciting field of imaging in multiple myeloma
Jens Hillengass et al.
Overview of CLL12 trial of ibrutinib aiming to delay chemoimmunotherapy
Selinexor for CLL - mechanism of action and combination with ibrutinib
The road to individualized treatment for CLL